Podcast Episodes
Back to SearchApprovals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.
We love to hear from our listeners. Send us a message.
Today's episode of the Business of Biotech covers a lot of ground with Enzyvant CEO Bill Symon…
3 years, 4 months ago
Next-Gen Nanobodies With MoonLake's Jorge Santos Da Silva, Ph.D.
We love to hear from our listeners. Send us a message.
The more we learn about inflammation and the complex cause/contributor/symptom roles it plays …
3 years, 5 months ago
Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.
We love to hear from our listeners. Send us a message.
On the surface, the merger of Medsenic (a developer of arsenic salt formulations for therapeut…
3 years, 5 months ago
TCRs In Personalized Oncology With BlueSphere Bio's Keir Loiacono
We love to hear from our listeners. Send us a message.
Among a growing cluster of Pittsburgh biotechs, you'll find BlueSphere Bio, an early-stage com…
3 years, 5 months ago
BoB@JPM: Self-Replicating RNA With Elixirgen's Akihiro Ko
We love to hear from our listeners. Send us a message.
SPECIAL EDITION: BoB@JPM
Elixirgen Therapeutics CEO Akihiro Ko joins the Business of Biotech fo…
3 years, 5 months ago
BoB@JPM: Gene Writing With Tessera's Michael Severino, M.D.
We love to hear from our listeners. Send us a message.
SPECIAL EDITION: BOB@JPM
Flagship Pioneering plucked Michael Severino, M.D. away from AbbVie to…
3 years, 6 months ago
BoB@JPM: Post-IPO With Bolt Biotherapeutics' Drs. Randall Schatzman and Edith Perez
We love to hear from our listeners. Send us a message.
SPECIAL EDITION: BOB@JPM
Bolt Biotherapeutics CEO Randall Schatzman, Ph.D. and CMO Edith Perez,…
3 years, 6 months ago
BoB@JPM: Academia To Industry With Oncolytics' Matt Coffey, Ph.D.
We love to hear from our listeners. Send us a message.
SPECIAL EDITION: BoB@JPM
The JP Morgan Healthcare Conference is a target-rich environment for c…
3 years, 6 months ago
BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.
We love to hear from our listeners. Send us a message.
SPECIAL EDITION: BoB@JPM
The Business of Biotech podcast took to the streets of San Francisco d…
3 years, 6 months ago
Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.
We love to hear from our listeners. Send us a message.
Is it past time for a new approach to the COVID vaccine? Ocugen Chairman of the Board, Founder…
3 years, 7 months ago